Clinical Trials - Genómica clínica - Mayo Clinic
COVID-19 consejos información actualizada y opciones de vacunas
Infórmate sobre la COVID-19 y las vacunas contra esta enfermedad, y conoce las novedades para pacientes y visitantes de Mayo Clinic. Para navegación del sitio Para acceso a contenido Este contenido no tiene una versión en inglés Este contenido no tiene una versión en árabe Departamentos y centros Genómica clínica
Clinical Trials
A continuación, se enumeran los ensayos clínicos actuales.
13 estudios en Genómica clínica
(solo estudios abiertos). Filtra esta lista de estudios por sede, estatus, etc. A Study of Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumors that are Recurrent or Cannot Be Removed by Surgery
Rochester, Minn. The purpose of this study is to assess the side effects and best dose of a genetically engineered measles virus for treating patients who have a cancerous peripheral nerve sheath tumor that cannot be removed by surgery (unresectable) or that has come back after a period of improvement (recurrent). Clinical and Basic Investigations into Congenital Disorders of Glycosylation
Rochester, Minn. The purpose of this study is to establish the prevalence and severity of specific morbid indicators of disease severity such as specific organ system involvement, degree of cognitive disability, and case-fatality associated with various congenital disorders of glycosylation (CDG), and establish a dynamic platform to effectively disperse clinically relevant findings to families, non-expert clinicians and researchers, as well as provide a verified method to link these individuals to experts in CDG. Study to Determine Effectiveness of Dietary Monosaccharide Supplementation in Patients with Congenital Disorders of Glycosylation
Rochester, Minn. The purpose of this study is to assess the safety and tolerability of oral monosaccharide (galactose and fucose) treatment in a small pilot group of congenital disorders of glycosylation patients. North American Mitochondrial Disease Consortium Patient Registry and Biorepository NAMDC
Rochester, Minn. The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders. A Study to Evaluate Patient Experience and Satisfaction with Predictive Genomic Testing Ordered Through SL3
Rochester, Minn. The purpose of this study is to better understand the impact of predictive genomic testing in the healthy adult population by assessing decisional satisfaction/regret, understanding of disease risk, lifestyle modifications, and satisfaction with the testing experience. A Study To Investigate The Safety Tolerability Pharmacokinetics And Pharmacodynamics Of RO7248824 In Participants With Angelman Syndrome
Rochester, Minn. The primary objective of this study is to investigate the safety and tolerability of RO7248824 in participants with Angelman Syndrome (AS) aged 1-12 years. A Study to Analyze Whole Methylome for Identification of Epigenetic Variations in Undiagnosed Congenital Disorders
Rochester, Minn. The purpose of this study is to analyze genome-wide methylation patterns in DNA from patients with suspected hereditary disorders but for whom all previous genetic testing has been negative and/or equivocal. Visual Outcomes in Patients with Neurofibromatosis Type 1
Rochester, Minn. The purpose of this study is to determine visual outcome in patients with neurofibromatosis type 1 (NF1). The study will also correlate visual outcome with the history of optic glioma based on previous MRI imaging and compare visual outcomes in treated and untreated adult NF1 patients with a history of optic glioma. GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake Risk Reducing Surgery or Intensive Imaging Surveillance
Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will aid women at risk of breast cancer in making a decision to take (or not take) medications to prevent breast cancer. Gemini Study to Evaluate the Integration of Cancer Genetic Testing into a Cancer Clinical Practice at Mayo Clinic at Arizona
Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ethnic populations seeking care at Mayo Clinic Arizona cancer clinics. Otros temas en atención en Mayo Clinic
Consultas Ubicación Guía para pacientes y visitantes Servicios internacionales Departamentos y centros médicos Doctores y personal médico Servicios en línea para pacientes Facturación y seguros Ensayos clínicos Colaboraciones comerciales internacionales Información sobre Mayo Clinic Contáctenos . Departamentos y centros Genómica clínica Clinical Trials Mayo Clinic Footer
Para consultasPara donarContáctanosMayo Clinic: InformaciónEmpleadosMapa del sitioSobre el sitio Legal Conditions and Terms
Cualquier uso de este sitio constituye su acuerdo con los términos y condiciones y política de privacidad para los que hay enlaces abajo. Términos y condiciones Política de privacidad Aviso de prácticas en cuanto a privacidad Para administrar cookies Advertising
Mayo Clinic es una organización sin fines de lucro, y el dinero recaudado con la publicidad en Internet apoya nuestra misión. Mayo Clinic no respalda ningún producto ni servicios de terceros que se anuncien.Política sobre publicidad y promociónOportunidades para publicidad y promoción Reprint Permissions
Se puede reimprimir una sola copia de estos materiales para usar en forma personal y no comercial. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," y el triple escudo que es el logotipo de Mayo Clinic son marcas registradas de Mayo Foundation for Medical Education and Research. 1998-2022 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.